11.25 Mg Leuprorelin Acetate Injection

Name: 11.25 Mg Leuprorelin Acetate Injection
Brand: NEETCO BIOPHARMA
Price: 3800 INR
Availability: InStock

Price 3800 INR/ Vial

Get a Price/Quote

MOQ : 12 Vials

11.25 Mg Leuprorelin Acetate Injection Specification

Indication
Palliative treatment of advanced prostate cancer, management of endometriosis, uterine fibroids, and precocious puberty

Dosage Form
Injection

Salt Composition
Leuprorelin Acetate 11.25 mg

Feature
Prolonged-release, effective for up to 3 months with single injection

Ingredients
Leuprorelin Acetate, excipients

Application
Administered by healthcare professionals for hormonal therapy

Physical Color/Texture
Lyophilized white to off-white powder

Fermentation Smell
Odorless

Storage Instructions
Store below 25C, protect from light and moisture

Shelf Life
24 months

Dosage Strength
Long-acting depot formulation for quarterly administration

ATC Code
L02AE02

Strength
11.25 mg per vial

Packaging Type
Single-use vial with diluent for reconstitution

Brand Name
Available as per market (Leucomax, Lucrin Depot, etc.)

Prescription Status
Prescription only

Contraindications
Known hypersensitivity to leuprorelin or similar compounds, pregnancy, and breastfeeding

CAS Number
74381-53-6

Route of Administration
Intramuscular injection

Usage
As directed by physician, standard dosing every 3 months

About 11.25 Mg Leuprorelin Acetate Injection

Experience rare efficacy and crackerjack savings with our top-notch 11.25 Mg Leuprorelin Acetate Injection. This polished solution is tailored for palliative care in advanced prostate cancer, endometriosis, uterine fibroids, and precocious puberty. Each single-use vial is blended with leuprorelin acetate (11.25 mg) and quality excipients, ensuring quarterly long-acting hormone therapy. Suitable for IM injection, this depot formulation provides prolonged-release benefits, up to 3 months per dose. Prescription-only, it is available under leading brands and distributed exclusively in India.

Precise Usage and Application Surface

11.25 Mg Leuprorelin Acetate Injection is a prescription drug utilized by healthcare professionals for hormonal therapy. Its use type is strictly as directed by a physician, with typical administration every three months. The application surface is intramuscular, allowing absorption directly into muscle tissue for sustained hormone release. Ideal for managing advanced prostate cancer and gynecological conditions, it ensures accurate dosing and effective results for eligible patients.

Sample Offer and Dispatch Policy

We offer sample availability for 11.25 Mg Leuprorelin Acetate Injection, providing a chance to evaluate our top-tier product before purchase. Samples are dispatched swiftly from designated FOB ports, ensuring prompt delivery for your needs. Our sample policy is affordable, with rates tailored for distributors, exporters, suppliers, or traders across India. Experience confidence in quality through our seamless offering and reliable sample dispatching process.

FAQ's of 11.25 Mg Leuprorelin Acetate Injection:

Q: How is the 11.25 Mg Leuprorelin Acetate Injection administered?

A: The injection is administered intramuscularly by a healthcare professional, typically every 3 months as prescribed by a physician.

Q: What are the main indications for this product?

A: It is primarily indicated for palliative treatment of advanced prostate cancer, management of endometriosis, uterine fibroids, and precocious puberty.

Q: When should this medication not be used?

A: It should not be used in individuals with known hypersensitivity to leuprorelin, in pregnancy, or while breastfeeding.

Q: Where should I store the 11.25 Mg Leuprorelin Acetate Injection?

A: Store the product below 25C, protecting it from light and moisture to maintain its shelf life of up to 24 months.

Q: What is the process for obtaining this injection?

A: The product is prescription-only and must be obtained from authorized distributors, exporters, suppliers, or traders in India with a valid prescription.

Q: How does the prolonged-release feature benefit patients?

A: The long-acting depot formulation allows for effective hormone therapy with just a single injection every three months, improving convenience and adherence.

Tell us about your requirement